Table 5: Adjusted EBITDA and Free Cash Flow (unaudited)
($ in millions) | Three months ended | Full-year | |||||||||||||||||
December 31, 2022 | October 2, 2022 | December 31, 2021 | 2022 | 2021 | |||||||||||||||
GAAP Net income (loss) | $ | 734 | $ | 750 | $ | 610 | $ | 2,833 | $ | 1,906 | |||||||||
Reconciling items to EBITDA (Non-GAAP) | |||||||||||||||||||
Financial (income) expense | 103 | 98 | 123 | 434 | 403 | ||||||||||||||
(Benefit) provision for income taxes | 137 | 149 | 72 | 529 | 272 | ||||||||||||||
Depreciation | 158 | 156 | 145 | 605 | 551 | ||||||||||||||
Amortization | 144 | 165 | 165 | 645 | 711 | ||||||||||||||
EBITDA (Non-GAAP) | $ | 1,276 | $ | 1,318 | $ | 1,115 | $ | 5,046 | $ | 3,843 | |||||||||
Reconciling items to adjusted EBITDA (Non-GAAP) | |||||||||||||||||||
Results of equity-accounted investees | 6 | 4 | 2 | 1 | 2 | ||||||||||||||
Restructuring | (2 | ) | — | — | (7 | ) | 1 | ||||||||||||
Stock based costs | 97 | 89 | 88 | 364 | 353 | ||||||||||||||
Other incidental items | 8 | 33 | 10 | 65 | 33 | ||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 1,385 | $ | 1,444 | $ | 1,215 | $ | 5,469 | $ | 4,232 | |||||||||
Trailing twelve month adjusted EBITDA (Non-GAAP) | $ | 5,469 | $ | 5,299 | $ | 4,232 | $ | 5,469 | $ | 4,232 | |||||||||
($ in millions) | Three months ended | Full-year | |||||||||||||||||
December 31, 2022 | October 2, 2022 | December 31, 2021 | 2022 | 2021 | |||||||||||||||
Net cash provided by (used for) operating activities | $ | 1,076 | $ | 1,144 | $ | 785 | $ | 3,895 | $ | 3,077 | |||||||||
Net capital expenditures on property, plant and equipment | (233 | ) | (281 | ) | (266 | ) | (1,061 | ) | (766 | ) | |||||||||
Non-GAAP free cash flow | $ | 843 | $ | 863 | $ | 519 | $ | 2,834 | $ | 2,311 | |||||||||
Trailing twelve month non-GAAP free cash flow | $ | 2,834 | $ | 2,510 | $ | 2,311 | $ | 2,834 | $ | 2,311 | |||||||||
Trailing twelve month non-GAAP free cash flow as percent of Revenue | 21 | % | 19 | % | 21 | % | 21 | % | 21 | % | |||||||||